Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis

NeuroImage

Volumn 70, Issue , 2013, Pages 113-121

  Daugherty, Ana ^a   Raz, Naftali ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Non heme iron; Red nucleus; Striatum; Substantia nigra

Indexed keywords

IRON;

AGE; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CORPUS STRIATUM; GLOBUS PALLIDUS; HUMAN; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; RED NUCLEUS; SUBSTANTIA NIGRA;

EID: 84872373597     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.12.040     Document Type: Article

References (82)

1. *Agartz I., Saaf J., Wahlund L.-O., Wetterberg L. T1 and T2 relaxation time estimates in the normal human brain. Radiology 1991, 181(2):537-543.
2. Anderson C.M., Kaufman M.J., Lowen S.B., Rohan M., Renshaw P.F., Teicher M.H. Brain T2 relaxation times correlate with regional cerebral blood volume. MGMA 2005, 181:3-6.
3. 2 relaxation time in patients with Parkinson's disease. Neurology 1993, 43:697-700.
4. *Aquino D., Bizzi A., Grisoli M., Garavaglia B., et al. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252(1):165-172.
5. Bartzokis G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 2011, 32(8):1341-1371.
6. *Bartzokis G., Mintz J., Sultzer D., Marx P., Herzberg J.S., Phelan C.K., Marder S.R. In vivo MR evaluation of age-related increases in brain iron. AJNR Am. J. Neuroradiol. 1994, 15(6):1129-1138.
7. Bartzokis G., Sultzer D., Mintz J., Holt L.E., Marx P., Phelan C.K., Marder S.R. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol. Psychiatry 1994, 35:480-487.
8. *Bartzokis G., Beckson M., Hance D., Marx P., Foster J., Marder S. MR evaluation of age-related increase of brain iron in young adult and older normal males. J. Magn. Reson. Imaging 1997, 15(1):29-35.
9. *Bartzokis G., Cummings J.L., Markham C.H., Marmarelis P.Z., et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. J. Magn. Reson. Imaging 1999, 17(2):213-222.
10. *Bartzokis G., Tishler T.A., Lu P.H., et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 2007, 28:414-423.
11. Bartzokis G., Lu P.H., Tishler T., Peters D., et al. Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J. Alzheimers Dis. 2010, 20:333-341.
12. Bartzokis G., Lu P., Tingus K., Peters D., et al. Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 2011, 36:1375-1384.
13. Berg D., Kruger R., RieB R., Riederer P. Parkinson's disease. Handbook of Neurochemistry and Molecular Neurobiology: Degenerative Diseases of the Nervous System 2007, 1-20. Springer, New York, NY. 3rd ed. M. Youdim, P. Riederer, S. Mandel, L. Battistin (Eds.).
14. *Bilgic B., Pfefferbuam A., Rohlfing T., Sullivan E., Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2011, 59(3):2625-2635.
15. Bizzi A., Brooks R.A., Brunetti A., et al. Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology 1990, 177:59-65.
16. Brass S.D., Chen N., Mulkern R., Baksni R. Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging 2006, 17(1):31-40.
17. Cabantchik Z.I., Kakhlon O., Epsztejn S., Zanninelli G., Breuer W. Intracellular and extracellular labile iron pools. Adv. Exp. Med Biol. 2002, 509:55-75.
18. *Cherubini A., Peran P., Caltagirone C., Sabatini U., Spalletta G. Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage 2009, 48:29-36.
19. Crichton R.R, Ward R.J. Structure and molecular biology of iron binding proteins and the regulation of 'free' iron pools. Iron and Human Disease 1992, 23-76. CRC Press, Roca Baton, FL. Lauffer (Ed.).
20. Drayer B. Imaging of the aging brain: part I. Normal findings. Radiology 1988, 166:785-796.
21. Fisher J., Ingram D., Slagle-Webb B., Madhankumar A.B., et al. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am. J. Physiol. Cell Physiol. 2006, 293:C641-C649.
22. Fukunaga M., Li T.Q., van Gelderen P., de Zwart J.A., Shmueli K., Yao B., Lee J., Maric D., Aronova M.A., Zhang G., Leapman R.D., Schenck J.F., Merkle H., Duyn J.H. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3834-3839.
23. Gomori G. Microtechnical demonstration of iron. A criticism of its methods. Am. J. Pathol. 1936, 12:655-663.
24. Gomori J., Grossman R. The relation between regional brain iron and T2 shortening. AJNR Am. J. Neuroradiol. 1993, 14:1049-1050.
25. Haacke E.M., Cheng N.Y.C., House M.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. J. Magn. Reson. Imaging 2005, 23(1):1-25.
26. *Haacke E.M., Miao Y., Liu M., Habib C.A., Katkuri Y., Liu T., Yang Z., Lang Z., Hu J., Wu J. Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J. Magn. Reson. Imaging 2010, 32:561-576.
27. Haacke E.M., Tang J., Neelavalli J., Cheng Y.C.N. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J. Magn. Reson. Imaging 2010, 32:663-676.
28. Hallervorden J., Spatz H. Peculiar disease of the extrapyramidal system with particular affection of the globus pallidus and the substantia nigra. Z. Ges. Neurol. Psychiatr. 1922, 79:254-302. Translation.
29. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3:41-51.
30. Halliwell B. Iron and damage to biomolecules. Iron and Human Disease 1992, 209-236. CRC Press, Roca Baton, FL. Lauffer (Ed.).
31. Hamilton M.L., Van Remmen H., Drake J., Yang H., et al. Does oxidative damage to DNA increase with age?. PNAS 2001, 98(18):10469-10474.
32. Harder S.L., Hopp K.M., Ward H., Neglio H., Gitlin J., Kido D. Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am. J. Neuroradiol. 2008, 29:176-183.
33. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11(3):298-300.
34. 2 relaxation, and volumetry of the naturally aging human caudate nuclei in healthy young and middle-aged adults: possible implications for the neurobiology of human brain aging and disease. Magn. Reson. Med. 2008, 59:7-13.
35. 2 relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications to understanding gray matter degeneration. J. Magn. Reson. Imaging 2009, 29(1):70-77.
36. Hedges L.V., Olkin I. Statistical Methods for Meta-analysis 1985, Academic Press, Orlando, FL.
37. House E., Collingwood J., Khan A., Korchazkina O., Berthon G., Exley C. Aluminum, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J. Alzheimers Dis. 2004, 6(3):291-301.
38. Jara H., Sakai O., Mankal P., Irving R., Norbash A. Multispectral quantitative magnetic resonance imaging of brain iron stores: a theoretical perspective. Top. Magn. Reson. Imaging 2006, 17:19-30.
39. Johnson B.T. DSTAT 1.10: Software for the Meta-analytic Review of Research Literatures 1993, Erlbaum, Hillsdale, NJ.
40. Joseph J.A., Shukitt-Hale B., Casadesus G., Fisher D. Oxidative stress and inflammation in brain aging: nutritional considerations. Neurochem. Res. 2005, 30(6/7):927-935.
41. *Kruit M.C., Launer L.J., Overbosch J., van Buchem M.A., Ferrari M.D. Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 2008, 29:351-359.
42. *Kumar R., Delshad S., Woo M.A., Macey P.M., Harper R.M. Age-related regional brain T2-relaxation changes in healthy adults. J. Magn. Reson. Imaging 2011, 35(2):300-308.
43. Langkammer C., Krebs N., Goessler W., Scheurer E., Yen K., Fazekas F., Ropele S. Susceptibility induced gray-white matter MRI contrast in the human brain. Neuroimage 2012, 59:1413-1419.
44. Introduction. Iron, aging, and human disease: historical background and new hypotheses. Iron and Human Disease 1992, 1-22. CRC Press, Boca Raton, FL. R. Lauffer (Ed.).
45. Lodygensky G.A., Marques J.P., Maddage R., Perroud E., Sizonenko S.V., Hüppi P.S., Gruetter R. In vivo assessment of myelination by phase imaging at high magnetic field. Neuroimage 2012, 59:1979-1987.
46. Maaroufi K., Ammari M., Jeljeli M., Roy V., Sakly M., Abdelmelek H. Impairment of emotional behavior and spatial learning in adult Winstar rats by ferrous sulfate. Physiol. Behav. 2009, 96:343-349.
47. *Martin W.R.W., Ye F.Q., Allen P.S. Increasing striatal iron content associated with normal aging. Mov. Disord. 1998, 13(2):281-286.
48. Maxwell S.E., Cole D.A. Bias in cross-sectional analyses of longitudinal mediation. Psychol. Methods 2007, 12(1):23-44.
49. Mills E., Dong X., Wang F., Xu H. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med. Chem. 2010, 2(1):51-72.
50. Moos T., Morgan E.H. The metabolism of neuronal iron and its pathogenic role in neurologic disease: review. Ann. N. Y. Acad. Sci. 2004, 1012:14-26.
51. Moos T., Rosengren Nielsen T., Skjorringe T., Morgan E.H. Iron trafficking inside the brain. J. Neurochem. 2007, 103(5):1730-1740.
52. Naderi S., Colakoglu Z., Luleci G. Calcification of basal ganglia associated with pontine calcification in four cases: a radiologic and genetic study. Clin. Neurol. Neurosurg. 1993, 95(2):155-157.
53. Ogg R.J., Langston J.W., Haacke E.M., Steen R.G., Taylor J.S. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. J. Magn. Reson. Imaging 1999, 17(8):1141-1148.
54. 2*-weighted MRI at 3Tesla. Magn. Reson. Med. 1994, 32:335-341.
55. Penke L., Valdés Hernandéz M.C., Maniega S.M., Gow A.J., Murray C., Starr J.M., Bastin M.E., Deary I.J., Wardlaw J.M. Brain iron deposits are associated with general cognitive ability and cognitive aging. Neurobiol. Aging 2012, 33(3):510-517. (Epub 2010 Jun 9).
56. Peran P., Hagberg G., Luccichenti G., et al. Voxel-based analysis of R2* maps in the healthy human brain. J. Magn. Reson. Imaging 2007, 26:1413-1420.
57. *Peran P., Cherubini A., Luccichenti G., et al. Volume and iron content in the basal ganglia and thalamus. Hum. Brain Mapp. 2009, 30:2667-2675.
58. *Pfefferbaum A., Adalsteinsson E., Rohfling T., Sullivan E.V. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 2009, 47(2):493-500.
59. *Pfefferbaum A., Adalsteinsson E., Rohlfing T., Sullivan E.V. Diffusion tensor imaging of deep gray matter brain structures: effects of age and iron concentration. Neurobiol. Aging 2010, 31(3):482-500.
60. *Pujol J., Junque C., Vendrell P., et al. Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch. Neurol. 1992, 49(7):711-717.
61. Quintana C., Bellefqih S., Laval J.Y., et al. Study of the localization of iron, ferritin, and hemosedrin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 2006, 153:42-54.
62. Radua J., Mataix-Cols D. Meta-analytic methods for neuroimaging data explained. Biol. Mood Anxiety Disord. 2012, 2(1):6-16.
63. Raz N., Kennedy K.M. A systems approach to the aging brain: neuroanatomic changes, their modifiers, and cognitive correlates. Imaging the Aging Brain 2009, 43-70. Oxford University Press. W. Jagust, M. D'Esposito (Eds.).
64. Raz N., Lindenberger U. News of cognitive cure for age-related brain shrinkage is premature: a comment on Burgmans et al. (2009). Neuropsychology 2010, 24(2):255-257.
65. Rival T., Page R.M., Chandraratna D.S., et al. Fenton chemistry and oxidative stress mediate the toxicity of the B-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur. J. Neurosci. 2009, 29:1335-1347.
66. *Rodrigue K.M., Haacke E.M., Raz N. Differential effects of age and history of hypertension of regional brain volumes and iron. Neuroimage 2011, 54:750-759.
67. Rodrigue K.M., Daugherty A.M., Haacke E.M., Raz N. The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory performance. Cereb. Cortex 2012, (Electronic publication ahead of print 2012 May 29).
68. Schenck J. Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths. J. Neurol. Sci. 1995, 134:10-18. (Suppl.).
69. Schenker C., Meier D., Wichmann W., Boesiger P., Valavanis A. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993, 35:119-124.
70. Siemonsen S., Finsterbusch J., Matschke J., Loernzen A., Ding X.-Q., Fiehler J. Age-dependent normal values of T2* and T2' in brain parenchyma. AJNR Am. J. Neuroradiol. 2008, 29:950-955.
71. Singh A., Isaac A.O., Luo X., Mohan M.L., Cohen M.L., Chen F., Kong Q., Bartz J., Singh N. Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog. 2009, 5:e1000336.
72. Spatz H. On the visualization of iron in the brain, especially in the centers of the extrapyramidal motor system. Z. Ges. Neurol. Psychiatr. 1922, 77:261-390. (In: Koeppen, A. (1992)).
73. Thomas L.O., Boyoko O.B., Anthony D.C., Burger P.C. MR detection of brain iron. AJNR Am. J. Neuroradiol. 1993, 14(5):1043-1048.
74. Tingey A.H. The iron content of the human brain-II. J. Ment. Sci. 1938, 84:980-984.
75. Todorich B., Pasquini J.M., Garcia C.I., Paez P.M., Connor J.R. Oligodendrocytes and myelination: the role of iron. Glia 2009, 57:467-478.
76. Vymazal J., Hajek M., Patronas N., Fiedd J.N., Butte J.W.M., Baurngarner C., Tran V., Brooks R.A. The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J. Magn. Reson. Imaging 1995, 5(5):554-560.
77. Vymazal J., Brooks R.A., Patronas N., Hajek M., Bulte J.W.M., Di Chiro G. Magnetic resonance imaging of brain iron in health and disease. J. Neurol. Sci. 1995, 134:19-26. (Suppl.).
78. Wagner M., Jurcoane A., Volz S., Magerkurth J., Zanella F.E., Neumann-Haefelin T., Deichmann R., Singer O.C., Hattingen E. Age-related changes of cerebral autoregulation: new insights with quantitative T2'-mapping and pulsed arterial spin-labeling MR imaging. AJNR Am. J. Neuroradiol. 2012, (Electronic publication ahead of print 2012 Jun 14).
79. Xiang Z., Nesterov E.E., Skoch J., Lin T., Hyman B.T., Swager T.M., Bacskai B.J., Reeves S.A. Detection of myelination using a novel histological probe. J. Histochem. Cytochem. 2005, 53:1511-1516.
80. *Xu X., Wang Q., Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 2008, 40:35-42.
81. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., Glaveri G., Aroslo P., Santambroglo P., Farlello R.G., Katatekin E., Klenlnman M.H., Turro N., Hornyklewicz O., Zucca F.A. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. PNAS 2004, 101(26):9843-9848.
82. Zhang S., Wang J., Song N., Xie J., Jiang H. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells. Neurobiol. Aging 2009, 30:1466-1476.